Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
about
Strategies on the nuclear-targeted delivery of genesSelf-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica NanoparticlesSynthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation.MC8 peptide-mediated Her-2 receptor targeting based on PEI-β-CyD as gene delivery vector.Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna DeliveryAn RNA alternative to human transferrin: a new tool for targeting human cells.Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Delivery of intracellular-acting biologics in pro-apoptotic therapies.Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.Targeting liposomes toward novel pediatric anticancer therapeutics.Nanocarriers: a tool to overcome biological barriers in siRNA delivery.Receptor-based targeting of therapeutics.Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers.Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.Liposome-targeted delivery for highly potent drugs.Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery.Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment.Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acidLight-Triggerable Liposomes for Enhanced Endolysosomal Escape and Gene Silencing in PC12 Cells.Use of β-galactosidase liposome model as a novel method to screen freeze-drying cryoprotectants.Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether Bond.Biomimetic strategies for targeted nanoparticle delivery.
P2860
Q26852376-B368CF19-618E-4A57-BC6F-716C4FA06D8EQ34427093-6694B6DB-8A97-421C-86F5-C847BBB9ACCBQ34441852-F308A4C1-5A4B-4E04-9132-9A3BB27826DFQ34504629-DB4E4194-3754-4B9D-9C78-AAE74F849C9DQ34785349-23ADFF45-1400-4B7B-89A9-A392AD9E3384Q36077849-057DC769-7222-4A65-BECE-63D311B52D48Q36396095-F5BE85CD-76E6-4382-9E8D-5F3727B88681Q36406637-A1E24ED7-1A03-4823-95C9-27AE450CB497Q36588920-9C71C6FB-879B-402A-AB18-2C0334592A04Q37020672-B18BD314-8EB6-4729-A325-4237DD65153DQ37684734-E0CB569F-7172-4FD6-B9A2-25EFEF44D174Q37891091-52F4ABD4-4CB7-4218-B7F7-7FAAEBF2B5CEQ38084739-AE63622A-CD98-4B06-800D-44E23EB3A8D1Q38139539-5E3A65A7-1D6F-4A30-8880-61215B5ACCEAQ38162098-BF598696-7CF3-40C9-8248-706C3E3994A0Q38940506-8F3C451C-E04B-4509-83F5-A5CFFE01537DQ39171223-A74D07CA-4007-456A-8E3A-31A10AC66407Q39197452-53CFCC46-087E-4419-BA68-2BBD36982ED2Q39236255-7019E840-F871-45E1-8E8C-57790A3465ACQ39615047-5F1DE257-9600-4619-A917-0F92546C10F2Q41459815-1EF5D10C-685F-455F-9BF6-6C8E3F39F94DQ41782832-2F70C5DD-C9D1-4B4A-A4BA-7099901101B3Q41822449-EC6BDBBA-3289-4872-90FA-D88E72230806Q44398986-2F6EE877-5FFF-4DEF-AAB8-2BE47FB4CADCQ50046023-81DBDDA8-D4A8-41A4-8273-7093D55C660DQ55209384-8657EE1C-F6FC-48B5-8AC5-4562EFFE0480
P2860
Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@en
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@nl
type
label
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@en
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@nl
prefLabel
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@en
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@nl
P2093
P356
P1476
Transferrin receptor-targeted ...... ic myeloid leukemia treatment.
@en
P2093
Filipe Firmino
João N Moreira
Liliana S Mendonça
Maria C Pedroso de Lima
Sérgio Simões
P304
P356
10.1021/BC9004365
P577
2010-01-01T00:00:00Z